Geriatrics

Interim findings from a cross-sectional study shows a correlation between worse cognitive scoring and a greater rate of intravitreal injections.

A new analysis of a trio of intravitreal agents show maintained visual acuity in treatment-naive patients for at least 5 years.

The specialty is on the precipice of advancement. What gets it over the hurdle?

A large proportion of nAMD patients treated with anti-VEGF therapies continue to have active disease and fluid.

A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.

How the condition affects both the vision and mindset of patients, and what clinical outcomes for anti-VEGF research do to address it.

A look at how primary care patients begin to present with diabetic retinopathy risk.

As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.

Cataracts and diabetic retinopathy are the 2 leading causes of acquired blindness worldwide.

It is important to understand how and why disease risk and health burden vary by socioeconomic status.

For the EMB treatment group, 65.6% of participants (n = 160) lost fewer than 15 ETDRS letters, while 86.6% (n = 103) in the ranibizumab group lost fewer than 15 ETDRS letters.

Those with ≥150 min per week in moderated or vigorous activities were low risk while those with less than 150 or sedentary activity were higher risk.

An analysis of data from a trio of phase 3 trials suggest use of the novel osteoporotic treatment could increase risk of heart attack by 18%.

Gauging patient wellbeing prior to intravitreal injections may help inform clinicians as to who may fare worse with the treatment.

The prevention of type 2 diabetes is possible and has important clinical benefits.

Discussing a look at the current life expectancy of patients with T2DM with an assistant professor from the University of Florida’s College of Pharmacy.

Increased physical activity could reduce the risk of developing age-related cataracts by up to 10%.

Sleeve gastrectomy is associated with less fracture risk than Roux-en-Y gastric bypass.

Analysis of the Framingham Heart Study indicates the rate of ICH in older patients has been on the rise and suggests anticoagulant use could have contributed to this increase.

A new analysis examines impact of treatment adherence in more than 1.2 million patients.

More patients maintain therapeutic response when treated concomitantly with methotrexate and pegloticase when compared to those who use pegloticase alone.

A team investigated data from trials of tofacitinib, adalimumab, and placebo.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

The findings can lead physicians to stop prescribing the drug.

Investigators estimate 40-50% of proton pump inhibitor users are using inappropriately.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

Investigators discover Veterans are not at a higher risk of developing dementia than civilians.

New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.

Despite patients being off treatment for an average of 23 months, patients treated with Eisai’s BAN2401 remained amyloid PET negative in an open-label extension preliminary analysis.